| MicroRNAs and metastasis: small RNAs play big roles |
44 |
| Causes, consequences, and therapy of tumors acidosis |
43 |
| The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond |
36 |
| Applications of Raman spectroscopy in cancer diagnosis |
32 |
| RNA interference-based therapy and its delivery systems |
31 |
| Mutations of key driver genes in colorectal cancer progression and metastasis |
31 |
| Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment |
30 |
| miR-155 in cancer drug resistance and as target for miRNA-based therapeutics |
29 |
| The Warburg metabolism fuels tumor metastasis |
28 |
| Update on gastric cancer treatments and gene therapies |
28 |
| Extracellular acidity and increased exosome release as key phenotypes of malignant tumors |
26 |
| Imaging tumor acidosis: a survey of the available techniques for mapping in vivo tumor pH |
21 |
| Cell surface-anchored serine proteases in cancer progression and metastasis |
20 |
| Current perspectives on bone metastases in castrate-resistant prostate cancer |
20 |
| Developing TRAIL/TRAIL death receptor-based cancer therapies |
20 |
| Non-coding RNAs, epigenetics, and cancer: tying it all together |
19 |
| Cancer-associated mucins: role in immune modulation and metastasis |
19 |
| The roles of the COX2/PGE2/EP axis in therapeutic resistance |
17 |
| Pleiotropic effects of moonlighting glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in cancer progression, invasiveness, and metastases |
16 |
| Pro-survival autophagy and cancer cell resistance to therapy |
16 |
| Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting |
15 |
| What is pH regulation, and why do cancer cells need it? |
14 |
| Long non-coding RNAs in metastasis |
13 |
| From biomarkers to therapeutic targets-the promises and perils of long non-coding RNAs in cancer |
13 |
| Acidosis and cancer: from mechanism to neutralization |
13 |
| Tumor pH and metastasis: a malignant process beyond hypoxia |
12 |
| MiR-181 family-specific behavior in different cancers: a meta-analysis view |
12 |
| Mucin glycoproteins block apoptosis; promote invasion, proliferation, and migration; and cause chemoresistance through diverse pathways in epithelial cancers |
12 |
| Platelets and extracellular vesicles in cancer: diagnostic and therapeutic implications |
12 |
| Omega-3 polyunsaturated fatty acids as adjuvant therapy of colorectal cancer |
12 |
| Stress, inflammation, and eicosanoids: an emerging perspective |
10 |
| WNT5A as a therapeutic target in breast cancer |
10 |
| Functional link between plasma membrane spatiotemporal dynamics, cancer biology, and dietary membrane-altering agents |
10 |
| The role of proteases in epithelial-to-mesenchymal cell transitions in cancer |
9 |
| Exosomes, metastases, and the miracle of cancer stem cell markers |
9 |
| Tackling tumor heterogeneity and phenotypic plasticity in cancer precision medicine: our experience and a literature review |
9 |
| Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer |
9 |
| Targeting lipid mediators in cancer biology |
9 |
| Novel roles of apoptotic caspases in tumor repopulation, epigenetic reprogramming, carcinogenesis, and beyond |
8 |
| Metabolic reprogramming of mitochondrial respiration in metastatic cancer |
8 |
| Role of prostaglandins in tumor microenvironment |
8 |
| The importance of 15-lipoxygenase inhibitors in cancer treatment |
8 |
| From genomics to metabolomics: emerging metastatic biomarkers in osteosarcoma |
8 |
| MACC1-the first decade of a key metastasis molecule from gene discovery to clinical translation |
8 |
| Role of autotaxin in cancer stem cells |
8 |
| Acidosis and proteolysis in the tumor microenvironment |
7 |
| Molecular and functional imaging insights into the role of hypoxia in cancer aggression |
7 |
| Exosomes as a storehouse of tissue remodeling proteases and mediators of cancer progression |
7 |
| KISS1 in breast Cancer progression and autophagy |
7 |
| Targeting the enzymes involved in arachidonic acid metabolism to improve radiotherapy |
7 |
